Long‐term survivor of pulmonary combined large cell neuroendocrine carcinoma treated with nivolumab
Author:
Affiliation:
1. Department of Oncology, Immunology and SurgeryNagoya City University Graduate School of Medical Sciences Nagoya Japan
2. Department of Pathology and Molecular DiagnosticsNagoya City University Graduate School of Medical Sciences Nagoya Japan
Publisher
Wiley
Subject
Pulmonary and Respiratory Medicine,Oncology,General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.13471
Reference14 articles.
1. The 2015 World Health Organization Classification of Lung Tumors
2. Pulmonary Large-Cell Neuroendocrine Carcinoma: From Epidemiology to Therapy
3. Disparity in clinical outcomes between pure and combined pulmonary large-cell neuroendocrine carcinoma: A multi-center retrospective study
4. Pulmonary Large Cell Neuroendocrine Carcinoma: Its Place in the Spectrum of Pulmonary Carcinoma⁎⁎A part of this report was presented by Iyoda A et al. Pulmonary large cell neuroendocrine carcinoma. JJLC 2006;46:315–20 [in Japanese with English abstract].
5. Neuroendocrine Neoplasms of the Lung: A Prognostic Spectrum
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Advances in combined neuroendocrine carcinoma of lung cancer;Pathology and Oncology Research;2024-05-14
2. Advances in genetic profile and therapeutic strategy of pulmonary large cell neuroendocrine carcinoma;Frontiers in Medicine;2024-02-27
3. Combined large cell neuroendocrine carcinoma, lung adenocarcinoma, and squamous cell carcinoma: a case report and review of the literature;Journal of Cardiothoracic Surgery;2023-08-31
4. Tumor intrinsic and extrinsic functions of CD73 and the adenosine pathway in lung cancer;Frontiers in Immunology;2023-03-24
5. Prognostic significance of YAP1 expression and its association with neuroendocrine markers in resected pulmonary large cell neuroendocrine carcinoma (LCNEC);Translational Oncology;2022-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3